Long intergenic non-protein coding RNA 1530 (LINC01530)

Long intergenic non-protein coding RNA 1530 (LINC01530) is a long non-coding RNA (lncRNA), meaning it is a transcribed RNA molecule longer than 200 nucleotides that does not encode a protein.[1][4][7] LINC01530 is an intergenic transcript—that is, it arises from a genomic region that does not overlap protein-coding genes.[4][1] LINC01530 has been reported to play regulatory roles in the cell, particularly in the context of cancer where it could influence gene expression and potentially contribute to tumorigenesis, though its precise functions and mechanisms remain incompletely characterized.[7] There is currently no evidence that LINC01530 serves as a direct therapeutic target (such as a receptor, enzyme, or transporter), nor are there clinically relevant drugs directed against it, established mechanisms of action, or validated biomarkers associated with it.[1][7][4] LINC01530 is a long non-coding RNA with associations to gene regulation and potential roles in cancer, but it is not currently recognized as a therapeutic target, druggable entity, or established biomarker. There are no approved or investigational drugs known to act via LINC01530, and its precise disease mechanisms remain incompletely understood[1][4][7][10].

Other names

FLJ30403LINC01530